AI Article Synopsis

  • Glycogen storage disorders (GSDs) are metabolic disorders caused by enzyme deficiencies affecting glycogen synthesis or breakdown, with GSD type IX linked to a deficiency in phosphorylase kinase.
  • A rare case of GSD type IXb was documented in a young boy with significant symptoms such as delayed motor skills and hepatosplenomegaly, leading to the discovery of a specific mutation in the PHKB gene.
  • The study underscores the genetic diversity among GSD IXb cases, suggesting that personalized diagnostic strategies are essential for effective identification and management.

Article Abstract

Glycogen storage disorders (GSDs) encompass a group of metabolic disorders resulting from deficiencies in enzymes involved in glycogen synthesis or breakdown. Among these, GSD type IX manifests due to a deficiency in phosphorylase kinase enzyme, leading to liver-specific, muscle-specific, or combined forms of the disorder. We present a case report of an exceedingly rare deletion-type mutation in the phosphorylase kinase B (PHKB) gene causing GSD type IXb, offering a comprehensive evaluation of clinical, laboratory, and molecular findings. A one-year and four-month-old male, born of third-degree consanguinity, presented with delayed motor milestones, hypotonicity, short stature, doll-like facies, and hepatosplenomegaly. Preliminary investigations revealed fasting hypoglycemia, ketonuria, elevated liver enzymes, and histological evidence of glycogen accumulation. Whole exome sequencing identified a homozygous deletion encompassing exons 2 to 10 of the PHKB gene, confirming the diagnosis of GSD IXb. GSD IXb due to PHKB mutations is rare, comprising only 10% of liver-specific GSD IX cases. Compared with similar cases reported in the literature, our analysis highlights the genetic heterogeneity within this subtype. Although clinical manifestations may overlap, specific genetic alterations vary, indicating that an individualized diagnostic approach is needed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345539PMC
http://dx.doi.org/10.7759/cureus.65474DOI Listing

Publication Analysis

Top Keywords

phosphorylase kinase
12
glycogen storage
8
type ixb
8
gsd type
8
phkb gene
8
gsd ixb
8
gsd
5
glycogen
4
storage disorder
4
disorder type
4

Similar Publications

Glycogen storage disorder types IX: the mutation spectrum and ethnic distribution.

Orphanet J Rare Dis

December 2024

Assistant Professor of Cellular and Molecular Medicine, Shiraz Transplant Research Center, Shiraz University of Medical Sciences, Khalili St., Research Tower, Seventh Floor, Shiraz, Iran.

Glycogen storage disorders (GSD) GSD-IX are characterized by deficiencies in muscular and/or hepatic phosphorylase enzymes. GSD type IX za is an X-linked disorder, while IXb and IXc are autosomal recessive disorders resulting from pathogenic variants in the genes encoding the Phosphorylase b Kinase regulatory subunit alpha (PHKA), beta (PHKB), and gamma (PHKG), respectively. Despite progress in understanding these diseases, there are still unclear questions regarding their clinical manifestations, genetic variations, and the relationship between genotype and phenotype.

View Article and Find Full Text PDF

Metabolic rewiring is required for cancer cells to survive in harsh microenvironments and is considered to be a hallmark of cancer. Specific metabolic adaptations are required for a tumor to become invasive and metastatic. Cell division and metabolism are inherently interconnected, and several cell cycle modulators directly regulate metabolism.

View Article and Find Full Text PDF

Toxoplasmosis remains a challenge for both public health and animal husbandry which created a constant demand to develop novel compounds using innovative methods. To join this relentless quest for an ideal chemotherapeutic agent, herein, we developed newly synthesized isatin-1,2,3-triazole derivatives. Three compounds (5a, 5b and 5c) were synthesized, characterized, loaded on chitosan nanoparticles (CNPs) and then evaluated accordingly.

View Article and Find Full Text PDF

Progressive liver disease and dysregulated glycogen metabolism in murine GSD IX γ2 models human disease.

Mol Genet Metab

December 2024

Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC, USA; Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA. Electronic address:

Hepatic glycogen storage disease type IX γ2 (GSD IX γ2) is a severe, liver-specific subtype of GSD IX. While all patients with hepatic GSD IX present with similar symptoms, over 95 % of patients with GSD IX γ2 progress to liver fibrosis and cirrhosis. Despite disease severity, the long-term natural history of GSD IX γ2 liver disease progression is not known.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores how licochalcone D (LicoD), derived from certain plants, can enhance glucose metabolism in liver cells (AML12) that are insulin resistant due to high glucose levels.
  • Researchers found that both hot water and ethanol extracts containing LicoD increased glucose uptake and improved genetic expression related to glucose metabolism in these cells.
  • The therapeutic effects of LicoD were linked to the activation of key biological pathways that reduce insulin resistance and enhance mitochondrial function, suggesting its potential as a treatment for related metabolic disorders.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!